Chemical Component Summary

NameN-{6-[(4-fluorobenzoyl)amino]hexanoyl}-L-gamma-glutamyl-5-{[(S)-{[(1S)-1,3-dicarboxypropyl]amino}(hydroxy)phosphoryl]oxy}-L-norvaline
Identifiers(2S)-2-[[[(4S)-4-[[(4S)-4-[6-[(4-fluorophenyl)carbonylamino]hexanoylamino]-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-5-oxidanyl-5-oxidanylidene-pentoxy]-oxidanyl-phosphoryl]amino]pentanedioic acid
FormulaC28 H40 F N4 O14 P
Molecular Weight706.608
TypeNON-POLYMER
Isomeric SMILESc1cc(ccc1C(=O)NCCCCCC(=O)N[C@@H](CCC(=O)N[C@@H](CCCOP(=O)(N[C@@H](CCC(=O)O)C(=O)O)O)C(=O)O)C(=O)O)F
InChIInChI=1S/C28H40FN4O14P/c29-18-9-7-17(8-10-18)25(38)30-15-3-1-2-6-22(34)32-20(27(41)42)11-13-23(35)31-19(26(39)40)5-4-16-47-48(45,46)33-21(28(43)44)12-14-24(36)37/h7-10,19-21H,1-6,11-16H2,(H,30,38)(H,31,35)(H,32,34)(H,36,37)(H,39,40)(H,41,42)(H,43,44)(H2,33,45,46)/t19-,20-,21-/m0/s1
InChIKeyIZLOSIXADNUSCM-ACRUOGEOSA-N

Chemical Details

Formal Charge0
Atom Count88
Chiral Atom Count3
Bond Count88
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB14965 
NameCTT-1057
Groups investigational
DescriptionCTT-1057 is under investigation in clinical trial NCT03427476 (CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma).
SynonymsCTT-1057
CAS number1628717-55-4

Related Resource References

Resource NameReference
Pharos CHEMBL3427435
PubChem 73386645
ChEMBL CHEMBL3427435